CD45+ erythroid progenitor cells as potential biomarkers for disease progression in hepatitis B virus-related acute-on-chronic liver failure
The percentage of CD45<sup>+</sup> EPCs in PBMCs may be a potential biomarker for predicting 28-day disease progression in patients with HBV-ACLF. These findings highlight their possible clinical utility for risk stratification.
Authors
- Zhiliang Gao (ORCID: https://orcid.org/0000-0001-7611-4416)
- Hongfei Wu (ORCID: https://orcid.org/0000-0001-6299-546X)
- Nan Zhang (ORCID: https://orcid.org/0000-0002-0941-482X)
- Xiu‐Qing Pang
- Xing Li (ORCID: https://orcid.org/0000-0001-9145-4769)
- Chunlin Yu (ORCID: https://orcid.org/0009-0000-5782-2249)
Institutions
- Sun Yat-sen University (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1186/s12876-025-03995-9
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Guangzhou Science and Technology Program key projects